Capital expenditure increased 98.9%
Capital expenditure changed +98.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +98.9% from the comparable as-filed period.
Inventory / revenue changed -531 basis points from the comparable as-filed period.
Debt / assets changed +337 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -27.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -717 basis points from the comparable as-filed period.
Research & development changed +18.0% from the comparable as-filed period.
Selling, general & administrative changed +13.7% from the comparable as-filed period.
SBC / revenue changed -50 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +68 basis points from the comparable as-filed period.
Free-cash-flow margin changed -152 basis points from the comparable as-filed period.
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Operating cash-flow margin changed -84 basis points from the comparable as-filed period.
R&D / revenue changed -35 basis points from the comparable as-filed period.
Current long-term debt changed +0.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +579.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed -765 basis points from the comparable as-filed period.
Research & development changed +28.3% from the comparable as-filed period.
Inventory changed +25.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +1185.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -42.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed -68 basis points from the comparable as-filed period.
Noncurrent long-term debt changed -15.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Reported total debt changed -15.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross debt changed -15.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +7.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Debt / revenue changed -8192 basis points from the comparable as-filed period.
Capital expenditure changed +27.2% from the comparable as-filed period.
Free-cash-flow margin changed +1452 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1423 basis points from the comparable as-filed period.
Selling, general & administrative changed +18.8% from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
SBC / revenue changed -75 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +6.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -29 basis points from the comparable as-filed period.
R&D / revenue changed -32 basis points from the comparable as-filed period.
Current long-term debt changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.